nilotinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
ni-lo-ti-nib
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Danziten
- Tasigna
Ther. Class.
Pharm. Class.
enzyme inhibitors
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Nilotinib." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109354/9/nilotinib.
Vallerand AHA, Sanoski CAC. Nilotinib. Davis's Drug Guide. F.A. Davis Company; 2026. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109354/9/nilotinib. Accessed June 28, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Nilotinib. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109354/9/nilotinib
Vallerand AHA, Sanoski CAC. Nilotinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 28]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109354/9/nilotinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - nilotinib
ID - 109354
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109354/9/nilotinib
PB - F.A. Davis Company
ET - 20
DB - Emergency Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

